Sponsor
Bharat Biotech in-licences GSK's Shigella vaccine candidate
Posted
Bharat Biotech has in-licensed GSK's Shigella vaccine candidate, altSonflex1-2-3, aimed at combating Shigellosis in young children in low- and middle-income countries. Following promising early-stage trials by GSK, Bharat Biotech will advance the vaccine through Phase-III trials, regulatory processes, and large-scale production. This collaboration strengthens Bharat Biotech's portfolio of vaccines against diarrheal infections.
Zoeken
Categorieën
- National
- International
- Business
- Technology
- Health
- Onderwijs
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
Nuclear sites hit, oil depot targeted: Israel-Iran trade heavy blows; key details
Following Israel's strike on Iran's nuclear facility, tensions have escalated dramatically....
Inside Arpita and Aayush's Mumbai home: PICS
Arpita Khan and Aayush Sharma's luxurious sea-facing apartment in Mumbai, showcased by Farah...
3D Wave in Mollywood
Mollywood is embracing 3D technology, with filmmakers exploring its potential beyond fantasy...
© 2025 Dununu.com : Circle of Life - Santan Social Network
Dutch
